12:00 AM
 | 
Sep 12, 2016
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Lorediplon: Completed Phase IIa enrollment

Ergomed completed enrollment of >=130 adult insomniacs in a double-blind, placebo-controlled, crossover, international Phase IIa trial comparing 5 and 10 mg oral lorediplon vs. zolpidem. Ferrer is conducting the trial in collaboration with CRO Ergomed and...

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >